Filter
50
Filtered Results: 50
Text search:
coronavac
Featured
Recommendations
4
Language
Document type
Guidelines
22
Studies & Reports
12
Fact sheets
6
Strategic & Response Plan
3
Training Material
2
Situation Updates
2
Resource Platforms
2
Online Courses
1
Countries / Regions
Brazil
5
Ukraine
4
Ecuador
3
Chile
3
Paraguay
3
Russia
3
Colombia
2
Germany
1
China
1
El Salvador
1
Middle East and North Africa
1
South–East Asia Region
1
Latin America and the Carribbean
1
Authors & Publishers
Publication Years
Category
Countries
25
Clinical Guidelines
2
Toolboxes
COVID-19
43
Conflict
2
Refugee
1
TB
1
Временное руководство (Первый выпуск 24 мая 2021 г., Обновлено 21 октября 2021 г., Обновлено 15 марта 2022 г.
This quick guide offers basic information about COVID-19, the Sinovac-CoronaVac COVID-19 vaccine and what to
expect following vaccination: ...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexe...
orientaciones provisionales, primera publicación: 24 de mayo de 2021, actualización: 21 de octubre de 2021, actualización: 15 de marzo de 2022
24 September 2021. The vaccine has been authorized by the Chinese National Regulatory Authority (NRA) – the National Medicinal Product Administration (NMPA) – as well as other regulatory authorities. Because WHO has granted Emergency Use Listing (EUL) for the Sinovac COVID-19 vaccine (Vero Cell ...
Guidelines for the Vaccination Plan against COVID-19 in children 5 to 11 years, 11 months, 29 days with COVID-19 Vaccine Coronovac / Sinovac
Вакцина против COVID-19 CoronaVac производства компании Sinovac (Sinovac-CoronaVac) July 2021
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed
to support decision making. A countrywide mass vaccination campaign with the
use of an inactivated severe acute respiratory syndrome c...
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp...
En Paraguay, la vacunación contra COVID-19 inició el 22 de febrero de 2021. Se han autorizado un total de siete vacunas: Bharat-Covaxin, Moderna, Pfizer-BioNTech, AstraZeneca, Sinopharm, Sputnik V- Gamaleya y CoronaVac-Sinovac. Los grupos priorita...
11 august 2022, updated version
Guidelines for the Vaccination Scheme against
COVID 19: Booster Dose Health Personnel
Este plano apresenta diretrizes gerais para a Campanha Nacional de Vacinação contra a Covid-19, de forma que especificidades e alterações de cenários conforme disponibilidade de vacinas serão informadas e divulgadas por meio de Informes Técnicos da Campanha Nacional de Vacinação, divulgados...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
